|
1
|
Hamza MA and Gilbert M: Targeted therapy
in gliomas. Curr Oncol Rep. 16:3792014. View Article : Google Scholar
|
|
2
|
Kaufmann JK and Chiocca EA: Glioma virus
therapies between bench and bedside. Neuro Oncol. 16:334–351. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lohkamp B, Bauerle B, Rieger PG and
Schneider G: Three-dimensional structure of iminodisuccinate
epimerase defines the fold of the MmgE/PrpD protein family. J Mol
Biol. 362:555–566. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee CG, Demarquoy J, Jackson MJ and
O’Brien WE: Molecular cloning and characterization of a murine
LPS-inducible cDNA. J Immunol. 152:5758–5767. 1994.PubMed/NCBI
|
|
5
|
Gautam A, Dixit S, Philipp MT, et al:
Interleukin-10 alters effector functions of multiple genes induced
by Borrelia burgdorferi in macrophages to regulate Lyme
disease inflammation. Infect Immun. 79:4876–4892. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Zhang P, Wang C, et al: Immune
responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing
A20 expression in macrophages through reactive oxygen species. J
Biol Chem. 288:16225–16234. 2013. View Article : Google Scholar
|
|
7
|
Lee CG, Jenkins NA, Gilbert DJ, Copeland
NG and O’Brien WE: Cloning and analysis of gene regulation of a
novel LPS-inducible cDNA. Immunogenetics. 41:263–270.
1995.PubMed/NCBI
|
|
8
|
Shi S, Blumenthal A, Hickey CM, Gandotra
S, Levy D and Ehrt S: Expression of many immunologically important
genes in Mycobacterium tuberculosis-infected macrophages is
independent of both TLR2 and TLR4 but dependent on IFN-alphabeta
receptor and STAT1. J Immunol. 175:3318–3328. 2005.PubMed/NCBI
|
|
9
|
Muccioli M, Sprague L, Nandigam H, Pate M
and Benencia F: Toll-like receptors as novel therapeutic targets
for ovarian cancer. ISRN Oncol. 2012:6421412012.PubMed/NCBI
|
|
10
|
Hall CJ, Boyle RH, Astin JW, et al:
Immunoresponsive gene 1 augments bactericidal activity of
macrophage-lineage cells by regulating β-oxidation-dependent
mitochondrial ROS production. Cell Metab. 18:265–278.
2013.PubMed/NCBI
|
|
11
|
Chiba Y, Mizoguchi I, Mitobe K, et al:
IL-27 enhances the expression of TRAIL and TLR3 inhuman melanomas
and inhibits their tumor growth in cooperation with a TLR3 agonist
poly(I:C) partly in a TRAIL-dependent manner. PLoS One.
8:e761592013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song Q, Li Y, Zheng X, et al: MTA1
contributes to actin cytoskeleton reorganization and metastasis of
nasopharyngeal carcinoma by modulating Rho GTPases and Hedgehog
signaling. Int J Biochem Cell Biol. 45:1439–1446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lathia JD, Li M, Hall PE, et al: Laminin
alpha 2 enables glioblastoma stem cell growth. Ann Neurol.
72:766–778. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheng L, Huang Z, Zhou W, et al:
Glioblastoma stem cells generate vascular pericytes to support
vessel function and tumor growth. Cell. 153:139–152. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Islam KN, Bae JW, Gao E and Koch WJ:
Regulation of nuclear factor κB (NF-κB) in the nucleus of
cardiomyocytes by G protein-coupled receptor kinase 5 (GRK5). J
Biol Chem. 288:35683–35689. 2013.
|
|
16
|
Cheah SC, Lai SL, Lee ST, Hadi AH and
Mustafa MR: Panduratin A, a possible inhibitor in metastasized A549
cells through inhibition of NF-kappa B translocation and
chemo-invasion. Molecules. 18:8764–8778. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao L, Wang H, Sun X and Ding Y:
Comparative proteomic analysis identifies proteins associated with
the development and progression of colorectal carcinoma. FEBS J.
277:4195–4204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang F, Qiao Y, Yu J, et al: FBX8 acts as
an invasion and metastasis suppressor and correlates with poor
survival in hepatocellular carcinoma. PLoS One. 8:e654952013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang J, Ye X, Guan J, et al: Tiam1 is
associated with hepatocellular carcinoma metastasis. Int J Cancer.
132:90–100. 2013. View Article : Google Scholar
|
|
20
|
Michelucci A, Cordes T, Ghelfi J, et al:
Immune-responsive gene 1 protein links metabolism to immunity by
catalyzing itaconic acid production. Proc Natl Acad Sci USA.
110:7820–7825. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kovesdi I, Reichel R and Nevins JR: E1A
transcription induction: enhanced binding of a factor to upstream
promoter sequences. Science. 231:719–722. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang WJ, Wu SP, Liu JB, et al: MYC
regulation of CHK1 and CHK2 promotes radioresistance in a stem
cell-like population of nasopharyngeal carcinoma cells. Cancer Res.
73:1219–1231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee HH, Lee SR and Leem SH:
Tristetraprolin regulates prostate cancer cell growth through
suppression of E2F1. J Microbiol Biotechnol. 24:287–294. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim MK, Kang YJ, Kim DH, et al: A novel
hydroxamic acid derivative, MHY218, induces apoptosis and cell
cycle arrest through downregulation of NF-κB in HCT116 human colon
cancer cells. Int J Oncol. 44:256–264. 2014.PubMed/NCBI
|
|
25
|
Kim A, Yim NH, Im M, Jung YP, Kim T and Ma
JY: Suppression of the invasive potential of highly malignant tumor
cells by KIOM-C, a novel herbal medicine, via inhibition of NF-κB
activation and MMP-9 expression. Oncol Rep. 31:287–297.
2014.PubMed/NCBI
|
|
26
|
Zhang W and Grivennikov SI: Top Notch
cancer stem cells by paracrine NF-κB signaling in breast cancer.
Breast Cancer Res. 15:3162013.PubMed/NCBI
|
